Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cross

Showing results (461-470 of 595) with videos related to

Pageof 60
Sort By:
Blood|February 7, 2025
The JAK2 46/1 haplotype influences PD-L1 expressionGonzalo Carreño-Tarragona, María Tiana, Raquel Rouco, et al.
JMIR Formative Research|September 8, 2023
Digital Application of Clinical Staging to Support Stratification in Youth Mental Health Services: Validity and Reliability StudyMin K Chong, Ian B Hickie, Shane P Cross, et al.
Blood|January 13, 2011
Novel imatinib-sensitive PDGFRA-activating point mutations in hypereosinophilic syndrome induce growth factor independence and leukemia-like diseaseChristian Elling, Philipp Erben, Christoph Walz, et al.
Leukemia|January 12, 2007
FIP1L1-PDGFRA in chronic eosinophilic leukemia and BCR-ABL1 in chronic myeloid leukemia affect different leukemic cellsB Crescenzi, A Chase, R La Starza, et al.
JAMA Psychiatry|August 29, 2019
Clinical Stage Transitions in Persons Aged 12 to 25 Years Presenting to Early Intervention Mental Health Services With Anxiety, Mood, and Psychotic DisordersFrank Iorfino, Elizabeth M Scott, Joanne S Carpenter, et al.
Genes, Chromosomes & Cancer|April 29, 2014
Identification and functional characterization of imatinib-sensitive DTD1-PDGFRB and CCDC88C-PDGFRB fusion genes in eosinophilia-associated myeloid/lymphoid neoplasmsDarko Gosenca, Beate Kellert, Georgia Metzgeroth, et al.
Scientific Reports|July 18, 2025
Clinical, morphological and genetic characteristics of patients with concurrent presence of JAK2 V617F and BCR::ABL1Nicole Naumann, Vito Dangelo, Johannes Lübke, et al.
Journal of Cancer Research and Clinical Oncology|March 7, 2021
Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative networkVivien Schäfer, Helen E White, Gareth Gerrard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2022
Superior Efficacy of Midostaurin Over Cladribine in Advanced Systemic Mastocytosis: A Registry-Based AnalysisJohannes Lübke, Juliana Schwaab, Nicole Naumann, et al.
Genes, Chromosomes & Cancer|April 28, 2009
Frequent upregulation of MYC in plasma cell leukemiaLaura Chiecchio, Gian Paolo Dagrada, Helen E White, et al.
Pageof 60

Showing results (461-470 of 595) with videos related to

Sort By:
Pageof 60
Blood|February 7, 2025
The JAK2 46/1 haplotype influences PD-L1 expressionGonzalo Carreño-Tarragona, María Tiana, Raquel Rouco, et al.
JMIR Formative Research|September 8, 2023
Digital Application of Clinical Staging to Support Stratification in Youth Mental Health Services: Validity and Reliability StudyMin K Chong, Ian B Hickie, Shane P Cross, et al.
Blood|January 13, 2011
Novel imatinib-sensitive PDGFRA-activating point mutations in hypereosinophilic syndrome induce growth factor independence and leukemia-like diseaseChristian Elling, Philipp Erben, Christoph Walz, et al.
Leukemia|January 12, 2007
FIP1L1-PDGFRA in chronic eosinophilic leukemia and BCR-ABL1 in chronic myeloid leukemia affect different leukemic cellsB Crescenzi, A Chase, R La Starza, et al.
JAMA Psychiatry|August 29, 2019
Clinical Stage Transitions in Persons Aged 12 to 25 Years Presenting to Early Intervention Mental Health Services With Anxiety, Mood, and Psychotic DisordersFrank Iorfino, Elizabeth M Scott, Joanne S Carpenter, et al.
Genes, Chromosomes & Cancer|April 29, 2014
Identification and functional characterization of imatinib-sensitive DTD1-PDGFRB and CCDC88C-PDGFRB fusion genes in eosinophilia-associated myeloid/lymphoid neoplasmsDarko Gosenca, Beate Kellert, Georgia Metzgeroth, et al.
Scientific Reports|July 18, 2025
Clinical, morphological and genetic characteristics of patients with concurrent presence of JAK2 V617F and BCR::ABL1Nicole Naumann, Vito Dangelo, Johannes Lübke, et al.
Journal of Cancer Research and Clinical Oncology|March 7, 2021
Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative networkVivien Schäfer, Helen E White, Gareth Gerrard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2022
Superior Efficacy of Midostaurin Over Cladribine in Advanced Systemic Mastocytosis: A Registry-Based AnalysisJohannes Lübke, Juliana Schwaab, Nicole Naumann, et al.
Genes, Chromosomes & Cancer|April 28, 2009
Frequent upregulation of MYC in plasma cell leukemiaLaura Chiecchio, Gian Paolo Dagrada, Helen E White, et al.
Pageof 60